Create a free Manufacturing.net account to continue

New bottle for Ingelvac MycoFLEX® simplifies mixing with Ingelvac CircoFLEX®

Ingelheim, Germany, 30 August 2012 – Boehringer Ingelheim has announced the European approval for its latest innovation in Animal Health:

Ingelheim, Germany, 30 August 2012 – Boehringer Ingelheim has announced the European approval for its latest innovation in Animal Health: the MycoFLEX® Headspace bottle, a simple and practical way to mix the two pig vaccines Ingelvac CircoFLEX® and Ingelvac MycoFLEX® for their simultaneous application. The headspace design – originally inspired by customer demand – allows the two vaccines to be mixed directly in the Ingelvac MycoFLEX® bottle, thus eliminating the need for an additional mixing vessel. 

Based on a European wide market research as much as 83 % of veterinarians who vaccinate their pigs against PCV2 (Porcine Circovirus type 2) and M. hyo (Mycoplasma hyopneumoniae) are mixing both vaccines.1 This provides several benefits in animal welfare (less stress for pigs through single-shot injection of the vaccine mix), farm economics (saving labour) and animal health (fewer chances for pathogen transfer via injection needles). The FLEXcombo® concept of the mixable stand alone vaccines is the first and only solution to protect pigs both against PCV2 and M.hyo with a single shot.

Ingelvac CircoFLEX® is established globally as customers’ number one choice for PCV2-vaccination while Ingelvac MycoFLEX® is the market leader in several countries, including USA, Germany, Denmark, Sweden, The Netherlands, Belgium, Italy, Poland, Czech Republic, Hungary, Mexico, Taiwan and South Korea.2

SOURCE